Anesthetic management of the illicit-substance-using patient

Current Opinion in Anaesthesiology

Volumn 18, Issue 3, 2005, Pages 315-324

  Hernandez, Marcelle ^a   Birnbach, David J ^a,b   Van Zundert, André A J ^c  

^a JACKSON MEMORIAL HOSPITAL   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c CATHARINA HOSPITAL   (Netherlands)

Author keywords

Anesthesia; Illicit substance abuse

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4 HYDROXYBUTYRIC ACID; ACETYLSALICYLIC ACID; ADRENALIN; ATROPINE; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CANNABIS; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONIDINE; COCAINE; DEXAMETHASONE; DEXMEDETOMIDINE; DEXTROPROPOXYPHENE; DIAMORPHINE; DIAZEPAM; DIPHENHYDRAMINE; DOXEPIN; ETOMIDATE; FENTANYL; FLUNITRAZEPAM; GABAPENTIN; GLYCERYL TRINITRATE; HALOTHANE; HYPNOTIC SEDATIVE AGENT; ILLICIT DRUG; KETAMINE; LABETALOL; LYSERGIDE; MESCALINE; METHADONE; MIDAZOLAM; MORPHINE; NALOXONE; NALTREXONE; ONDANSETRON; OPIATE; OXYCODONE; PANCURONIUM; PENTAZOCINE; PETHIDINE; PHENCYCLIDINE; PHENOTHIAZINE DERIVATIVE; PHENTOLAMINE; PROPOFOL; PSILOCYBINE; PSYCHEDELIC AGENT; SOLVENT; SUXAMETHONIUM; THIOPENTAL; VERAPAMIL;

ANESTHESIOLOGICAL TECHNIQUES; CARDIOVASCULAR SYSTEM; COCAINE DEPENDENCE; DRUG INTOXICATION; DRUG TOLERANCE; ELECTIVE SURGERY; HUMAN; INTRAVENOUS DRUG ABUSE; LIVER; MULTIPLE DRUG ABUSE; NAUSEA AND VOMITING; OBSTETRIC ANALGESIA; PRIORITY JOURNAL; RESPIRATORY SYSTEM; RESUSCITATION; REVIEW; SEIZURE; SUBSTANCE ABUSE; URINARY TRACT;

EID: 20444363453     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aco.0000169241.21680.0b     Document Type: Review

References (56)

1. US Department of Heath and Human Services. National Survey on Drug Use and Health. Washington DC: US Department of Health and Human Services; 2003.
2. Demetriades D, Gkiokas G, Velmahos GC, et al. Alcohol and illicit drugs in traumatic deaths: prevalence and association with type and severity of injuries. J Am Coll Surg 2004; 199:687-692. Interesting study in an academic Level I Trauma Center evaluating the association of substance abuse with type and severity of injury, age group and ethnicity.
3. Movig KL, Mathijssen MP, Nagel PH, et al. Psychoactive substance use and the risk of motor vehicle accidents. Accid Anal Prev 2004; 36:631-636. A prospective observational case-control study performed to prove that driving performance is impaired with the use of alcohol, licit and illicit drugs. Authors concluded that drug use increased the risk of road trauma requiring hospitalization.
4. Kak V, Chandrasekar PH. Bone and joint infections in injection drug users. Infect Dis Clin North Am 2002; 16:681-695.
5. Bolnick JM, Rayburn WF. Substance use disorders in women: special considerations during pregnancy. Obstet Gynecol Clin North Am 2003; 30:545-558.
6. Birnbach DJ, Browne IM, Kim A, et al. Identification of polysubstance abuse in the parturient. Br J Anaesth 2001; 87:488-490.
7. Greydanus DE, Patel DR. Substance abuse in adolescents: a complex conundrum for the clinician. Pediatr Clin North Am 2003; 50:1179-1223.
8. Kuczkowski KM. Marijuana in pregnancy. Ann Acad Med Singapore 2004; 33:336-339. Excellent review of the obstetric anesthetic management of parturients abusing this recreational drug, which is of relevance because not much is published about the unpredictable clinical picture and the impact on the fetus.
9. Maykut MO. Health consequences of acute and chronic marijuana use. Prog Neuropsychopharmacol Biol Psychiatry 1985; 9:209-238.
10. Haney M, Hart CL, Vosburg SK, et al. Marijuana withdrawal in humans: effects of oral THC or divalproex. Neuropsychopharmacology 2004; 29:158-170. This study suggests the possible treatments for withdrawal symptoms in marijuana dependence.
11. Mills PM, Penfold N. Cannabis abuse and anaesthesia. Anaesthesia 2003; 58:1125.
12. Symons IE. Cannabis smoking and anaesthesia. Anaesthesia 2002; 57:1142-1143.
13. Cornelius MD, Taylor PM, Geva D, Day NL. Prenatal tobacco and marijuana use among adolescents: effects on offspring gestational age, growth, and morphology. Pediatrics 1995; 95:738-743.
14. Musty RE, Reggio P, Consroe P. A review of recent advances in cannabinoid research and the 1994 International Symposium on Cannabis and the Cannabinoids. Life Sci 1995; 56:1933-1940.
15. US Department of Heath and Human Services. Cocaine abuse and addiction. National Institute on Drug Abuse Research Report Series. Washington DC: US Department of Health and Human Services; 2002.
16. Kuczkowski KM. The cocaine abusing parturient: a review of anesthetic considerations. Can J Anaesth 2004; 51:145-154. This article is a comprehensive review of the perioperative anesthetic management of parturients with cocaine abuse: its diagnosis, its impact on administration of obstetric anesthesia and its life-threatening complications.
17. Carrera MR, Meijler MM, Janda KD. Cocaine pharmacology and current pharmacotherapies for its abuse. Bioorg Med Chem 2004; 12:5019-5030. Interesting article citing studies where immunopharmacotherapy has been proposed as a means to alleviate cocaine addiction.
18. Schindler CW. Cocaine and cardiovascular toxicity. Addict Biol 1996; 1:31-47.
19. Hsue PY, Saunas CL, Bolger AF, et al. Acute aortic dissection related to crack cocaine. Circulation 2002; 105:1592-1595.
20. Shanti CM, Lucas CE. Cocaine and the critical care challenge. Crit Care Med 2003; 31:1851-1859.
21. Lange RA, Hillis LD. Cardiovascular complications of cocaine use. N Engl J Med 2001; 345:351-358.
22. Kuczkowski KM, Birnbach DJ, van Zundert A. Drug abuse in the parturient. Sem Anesthesiol Periop Med Pain 2000; 19:216-224.
23. Vertommen JD, Hughes SC, Rosen MA, et al. Hydralazine does not restore uterine blood flow during cocaine-induced hypertension in the pregnant ewe. Anesthesiology 1992; 76:580-587.
24. Murphy JL Jr. Hypertension and pulmonary oedema associated with ketamine administration in a patient with a history of substance abuse. Can J Anaesth 1993; 40:160-164.
25. Jatlow P, Barash PG, Van Dyke C, et al. Cocaine and succinylcholine sensitivity: a new caution. Anesth Analg 1979; 58:235-238.
26. Whittington RA, Virag L, Vulliemoz Y, et al. Dexmedetomidine increases the cocaine seizure threshold in rats. Anesthesiology 2002; 97:693-700.
27. Inouye DS, Navin JJ, Hardman JM. Fatal postoperative arrhythmia in a man with a remote history of methamphetamine and cocaine use: a case report. Hawaii Med J 2004; 63:82-86. A case report outlining the importance of assuming subclinical cardiovascular pathology in patients abusing cocaine or met amphetamines.
28. Vagts DA, Boklage C, Galli C. Intraoperative ventricular fibrillation in a patient with chronic cocaine abuse - a case report [in German]. Anaesthesiol Reanim 2004; 29:19-24. A case report showing that severe cardiovascular complications may ensue while providing anesthesia, especially if the patient does not comply with a 1-week cocaine-free interval before elective procedures.
29. de Mendoza Asensi D, Rodriguez Jornet A, Carvajal Diaz A, et al. Acute renal insufficiency associated to cocaine consumption. Rev Clin Esp 2004; 204:206-211. Case reports of cocaine-abusing patients who present with acute renal insufficiency.
30. Terra Filho M, Yen CC, Santos Ude P, et al. Pulmonary alterations in cocaine users. Sao Paulo Med J 2004; 122:26-31. Review based on information and experience from treating cocaine abusers and the associated pulmonary complications.
31. Kuczkowski KM. Anesthetic implications of drug abuse in pregnancy. J Clin Anesth 2003; 15:382-394.
32. Kuczkowski KM, Benumof JL. Cesarean section in a parturient with HIV and recent cocaine and alcohol intake: anesthetic implications. Int J Obstet Anesth 2002; 11:135-137.
33. Moore TR, Sorg J, Miller L, et al. Hemodynamic effects of intravenous cocaine on the pregnant ewe and fetus. Am J Obstet Gynecol 1986; 155:883-888.
34. Andres RL. Social and illicit drug use in pregnancy. In: Resnik RR, Ceasy R, editors. Maternal-fetal medicine. Philadelphia: WB Saunders; 1993. pp. 145-164.
35. Davidson C, Lazarus C, Lee TH, Ellinwood EH. Ondansetron, given during the acute cocaine withdrawal, attenuates oral cocaine self-administration. Eur J Pharmacol 2004; 503:99-102. New approaches to cocaine-abuse therapy are been studied during the acute withdrawal period, suggesting this could be an important treatment window.
36. Liu XS, Chen YC, Li ZH. Study on the changes of electrocardiogram and ultrastructural in heroin dependence in rats. Fa Yi Xue Za Zhi 2004; 20(129-132):135. This study suggests the possible mechanism of myocardial injury by heroin.
37. Gold MS, Pottash AC, Sweeney DR, Kleber HD. Opiate withdrawal using clonidine. A safe, effective, and rapid nonopiate treatment. JAMA 1980; 243:343-346.
38. Koppel BS, Tuchman AJ, Mangiardi JR, et al. Epidural spinal infection in intravenous drug abusers. Arch Neurol 1988; 45:1331-1337.
39. Hughes SC, Dailey PA, Landers D, et al. Parturients infected with human immunodeficiency virus and regional anesthesia. Clinical and immunologic response. Anesthesiology 1995; 82:32-37.
40. Resnick L, Berger JR, Shapshak P, Tourtellotte WW. Early penetration of the blood-brain barrier by HIV. Neurology 1988; 38:9-14.
41. Warltier DC, Mitra S, Sinatra RS. Perioperative management of acute pain in the opioid-dependent patient. Anesthesiology 2004; 101:212-227. This article addresses the issue of the decreased tolerance to opioids that patients abusing these drugs may exhibit perioperatively, influencing the care anesthesiologists provide.
42. Kaye AD, Gevirtz C, Bosscher HA, et al. Ultrarapid opiate detoxification: a review. Can J Anaesth 2003; 50:663-671.
43. Klein M, Kramer F. Rave drugs: pharmacological considerations. Am Assoc Nurse Anesthetists J 2004; 72:61-67. A comprehensive review of drugs use by the young adult population, its physiological effects and potential risks with concurrent administration of anesthesia.
44. Fiege M, Wappler F, Weisshorn R, et al. Induction of malignant hyperthermia in susceptible swine by 3,4-methylenedioxymethamphetamine ("ecstasy"). Anesthesiology 2003; 99:1132-1136.
45. Brauer RB, Heidecke CD, Nathrath W, et al. Liver transplantation for the treatment of fulminant hepatic failure induced by the ingestion of ecstasy. Transpl Int 1997; 10:229-233.
46. Newman LM. The chemically dependent parturient. Sem Anesth 1992; 11:66-75.
47. Eriksson M, Jonsson B, Zetterstrom R. Children of mothers abusing amphetamine: head circumference during infancy and psychosocial development until 14 years of age. Acta Paediatr 2000; 89:1474-1478.
48. Nelson MM, Forfar JO. Associations between drugs administrered during pregnancy and congenital abnormalities of the fetus. BMJ 1971; 1:523-527.
49. Reneman L, Habraken JB, Majoie CB, et al. MDMA ("Ecstasy") and its association with cerebrovascular accidents: preliminary findings. AJNR Am J Neuroradiol 2000; 21:1001-1007.
50. Ghuran A, van Der Wieken LR, Nolan J. Cardiovascular complications of recreational drugs. BMJ 2001; 323:464-466.
51. Magee C, Staunton H, Tormey W, et al. Hyponatraemia, seizures and stupor associated with ecstasy ingestion in a female. Ir Med J 1998; 91:178.
52. Brody S, Krause C, Veit R, Rau H. Cardiovascular autonomic dysregulation in users of MDMA ("Ecstasy"). Psychopharmacology (Berlin) 1998; 136:390-393.
53. Saavedra H, De Marinis A, Palestini M. Neuronal changes induced by chronic toluene exposure in the cat. Arch Ital Biol 1996; 134:217-225.
54. Lolin Y. Chronic neurological toxicity associated with exposure to volatile substances. Hum Toxicol 1989; 8:293-300.
55. Jones HE, Balster RL. Inhalant abuse in pregnancy. Obstet Gynecol Clin North Am 1998; 25:153-167.
56. Wilkins-Haug L. Teratogen update: toluene. Teratology 1997; 55:145-151.